Updates on Recent Foreign Approvals and Launches
LexBlog IP
JUNE 6, 2023
Alkem’s CETUXA has been researched and manufactured by Enzene Biosciences Limited, the biological arm of Alkem. Sandeep Singh, Managing Director at Alkem, said, “[c]etuximab’s reach in India is limited partly due to its high cost and only around 2 percent of eligible patients are managed by this therapy.
52 
Let's personalize your content